National Assessment of Breast and Cervical Cancer Screening Using National Health Interview Survey
Author(s)
Ansh Kulkarni1, Aunovro H. Sen, Other2, Sohah Kulkarni, Other3, Rajesh Balkrishnan, PhD4;
1The College of New Jersey, Ewing, NJ, USA, 2Rutgers Prep, Somerset, NJ, USA, 3Princeton Day School, Princeton, NJ, USA, 4University of Virginia, Charlottesville, NJ, USA
1The College of New Jersey, Ewing, NJ, USA, 2Rutgers Prep, Somerset, NJ, USA, 3Princeton Day School, Princeton, NJ, USA, 4University of Virginia, Charlottesville, NJ, USA
OBJECTIVES: Breast and cervical cancers remain one of the most diagnosed women cancers in the United States. Early tumor identification through screening has significantly improved the prognosis of these cancers in women. This study will identified screening rates for breast cancer using mammogram and cervical cancers using PAP smear in the US and assessed the demographic characteristics of screened women.
METHODS: To study the national screening rates for breast and cervical cancer we used National health interview survey (NHIS) data from 2019, 2021, 2023. NHIS collects information about the health of the US population including access to healthcare services. To assess the cancer screening rates, we utilized an annual Cancer Control Supplement (CCS) which gathers information on practices of cancer-related health behaviors. Descriptive statistics were used to report the screening rates and demographic characteristics. Appropriates sampling weights were used to derive national estimates.
RESULTS: A total of 73,700 sample of adult women who were screened for breast and cervical cancer were included in this study. Nationally breast cancer rates across three years 2019, 2021, 2023 were 77.68%, 77.22% and 78.38%, respectively. Likewise, the rate of cervical cancer across three assessment years 2019, 2021, 2023 were 82.87%, 82.19% and 78.97%, respectively. On average rate of screening for breast (12.09%) and cervical cancer (12.29%) were slightly lower in Black women across all the years as compared to their national representation as per census bureau. Among the screened women insurance coverage was higher, majority of the screened women were from urban areas and were college graduates.
CONCLUSIONS: Rates of breast and cervical cancer screening remain higher across all the years. There are demographic differences among screened women in the United States with Black women consistently having lower rates of cancer screening. Additionally, access to health insurance is a strong driver to access screening services.
METHODS: To study the national screening rates for breast and cervical cancer we used National health interview survey (NHIS) data from 2019, 2021, 2023. NHIS collects information about the health of the US population including access to healthcare services. To assess the cancer screening rates, we utilized an annual Cancer Control Supplement (CCS) which gathers information on practices of cancer-related health behaviors. Descriptive statistics were used to report the screening rates and demographic characteristics. Appropriates sampling weights were used to derive national estimates.
RESULTS: A total of 73,700 sample of adult women who were screened for breast and cervical cancer were included in this study. Nationally breast cancer rates across three years 2019, 2021, 2023 were 77.68%, 77.22% and 78.38%, respectively. Likewise, the rate of cervical cancer across three assessment years 2019, 2021, 2023 were 82.87%, 82.19% and 78.97%, respectively. On average rate of screening for breast (12.09%) and cervical cancer (12.29%) were slightly lower in Black women across all the years as compared to their national representation as per census bureau. Among the screened women insurance coverage was higher, majority of the screened women were from urban areas and were college graduates.
CONCLUSIONS: Rates of breast and cervical cancer screening remain higher across all the years. There are demographic differences among screened women in the United States with Black women consistently having lower rates of cancer screening. Additionally, access to health insurance is a strong driver to access screening services.
Conference/Value in Health Info
2025-05, ISPOR 2025, Montréal, Quebec, CA
Value in Health, Volume 28, Issue S1
Code
EPH2
Topic
Epidemiology & Public Health
Topic Subcategory
Public Health
Disease
SDC: Oncology